IQVIA brings together exceptional expertise in Cell and Gene Therapy (CAGT) across the Cell and Gene Therapy development lifecycle, to help you increase the efficiency of your program and maximize the value of new therapies.
IQVIA established the Cell and Gene Therapy Center of Excellence in 2019 to develop patient-centered, data driven, hand-tailored strategies for CAGT trials. With the ultimate goal of getting new treatments to patients faster.
Leveraging in-depth therapeutic expertise and operational leadership, IQVIA is prepared to be your CRO partner - providing end-to-end expertise and services, tailored to the needs of CAGT drug development.